Validating a composite endpoint for acceptability evaluation of oral drug formulations in the pediatric population: a randomized, open-label, single dose, cross-over study

• Váldodahkkit: Juliane Münch (Dahkki), Anna Lena Schwarzwälder (Dahkki), Carolin Kloft (Dahkki), Hans Martin Bosse (Dahkki), Manfred Wargenau (Dahkki), Sibylle Reidemeister (Dahkki), Ingrid Klingmann (Dahkki), Viviane Klingmann (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

ObjectiveThis study aimed to validate the newly developed composite acceptability endpoint to investigate acceptability of oral pediatric drug formulations that integrates swallowability and palatability assessments.MethodsIn this open-label study acceptability of oral formulations was tested in thr...